StockWatch
·
Biotechnology: Pharmaceutical Preparations
DelistingNov 20, 2026, 05:16 PM

Ainos, Inc. Faces Nasdaq Delisting Warning Over Equity Shortfall

AI Summary

Ainos, Inc. received a notification from Nasdaq for failing to meet the Minimum Stockholders' Equity Requirement of $2,500,000, reporting $1,721,037 as of September 30, 2026. The company has 45 days to submit a plan to regain compliance, with potential extensions up to 180 days. Ainos is exploring measures like debt-to-equity conversion and capital raising.

Key Highlights

  • Ainos, Inc. notified by Nasdaq for non-compliance with Minimum Stockholders' Equity Requirement.
  • Company reported stockholders' equity of $1,721,037 as of September 30, 2026.
  • Nasdaq Listing Rule 5550(b)(1) requires at least $2,500,000 in stockholders' equity.
  • Ainos has 45 days (until January 4, 2027) to submit a plan to regain compliance.
  • Potential measures include debt conversion to equity and capital raising.
  • Nasdaq may grant an extension of up to 180 days if the plan is accepted.